DA
Denali Advisors Portfolio holdings
AUM
$960M
1-Year Return
20.62%
This Quarter Return
+6.28%
1 Year Return
+20.62%
3 Year Return
+77.88%
5 Year Return
+175.56%
10 Year Return
+248.86%
AUM
$340M
AUM Growth
+$12.3M
(+3.8%)
Cap. Flow
+$1.2M
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
16.29%
Holding
514
New
63
Increased
137
Reduced
118
Closed
64
Top Buys
| 1 |
Graham Holdings Company
GHC
|
$4.15M |
| 2 |
Simmons First National
SFNC
|
$3.58M |
| 3 |
Navient
NAVI
|
$2.64M |
| 4 |
PennyMac Financial
PFSI
|
$2.43M |
| 5 |
ARCH
Arch Resources, Inc.
ARCH
|
$2.43M |
Top Sells
| 1 |
Essent Group
ESNT
|
$5.06M |
| 2 |
Enova International
ENVA
|
$4.84M |
| 3 |
Stewart Information Services
STC
|
$3.08M |
| 4 |
Beazer Homes USA
BZH
|
$2.72M |
| 5 |
Customers Bancorp
CUBI
|
$2.68M |
Sector Composition
| 1 | Financials | 32.19% |
| 2 | Consumer Discretionary | 14.38% |
| 3 | Industrials | 13.77% |
| 4 | Energy | 9.52% |
| 5 | Consumer Staples | 6.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
inTEST
INTT
$90.7M
| $199K | 0.06% |
15,000
| – | – |
|
227
Olympic Steel
ZEUS
$379M
| $198K | 0.06% |
2,800
-3,900
| -58% | -$276K |
|
|
UHT
228
Universal Health Realty Income Trust
UHT
$574M
| $198K | 0.06% |
5,400
+2,000
| +59% | +$73.4K |
|
229
Dow Inc
DOW
$17.4B
| $197K | 0.06% |
3,400
| – | – |
|
230
CoreCard
CCRD
$212M
| $193K | 0.06% |
17,447
| – | – |
|
231
Allient
ALNT
$772M
| $189K | 0.06% |
+5,300
| New | +$189K |
|
232
Erasca
ERAS
$457M
| $188K | 0.06% |
91,200
| – | – |
|
233
Silvercrest Asset Management
SAMG
$134M
| $187K | 0.05% |
11,800
| – | – |
|
234
Cirrus Logic
CRUS
$5.94B
| $186K | 0.05% |
2,012
-602
| -23% | -$55.7K |
|
235
Castle Biosciences
CSTL
$683M
| $186K | 0.05% |
+8,400
| New | +$186K |
|
236
Copart
CPRT
$47B
| $185K | 0.05% |
3,200
+800
| +33% | +$46.3K |
|
237
Distribution Solutions Group
DSGR
$1.48B
| $184K | 0.05% |
5,200
| – | – |
|
|
BRT
238
BRT Apartments
BRT
$282M
| $181K | 0.05% |
10,800
| – | – |
|
239
Garmin
GRMN
$45.7B
| $179K | 0.05% |
+1,204
| New | +$179K |
|
240
Werewolf Therapeutics
HOWL
$61.7M
| $172K | 0.05% |
+26,600
| New | +$172K |
|
|
INZY
241
DELISTED
Inozyme Pharma
INZY
| $169K | 0.05% |
22,000
| – | – |
|
242
EVI Industries
EVI
$362M
| $167K | 0.05% |
6,700
| – | – |
|
243
StoneX
SNEX
$5.37B
| $164K | 0.05% |
3,497
+3,446
| +6,757% | +$161K |
|
244
Assertio
ASRT
$76.8M
| $158K | 0.05% |
165,200
+122,500
| +287% | +$118K |
|
245
Aldeyra Therapeutics
ALDX
$334M
| $155K | 0.05% |
+47,300
| New | +$155K |
|
246
Energy Services of America
ESOA
$165M
| $154K | 0.05% |
+18,700
| New | +$154K |
|
247
Destination XL Group
DXLG
$66.8M
| $153K | 0.05% |
42,500
| – | – |
|
248
Weyco Group
WEYS
$294M
| $150K | 0.04% |
4,700
+2,200
| +88% | +$70.1K |
|
249
Ennis
EBF
$476M
| $148K | 0.04% |
7,200
| – | – |
|
|
CWBC
250
Community West Bancshares
CWBC
$406M
| $147K | 0.04% |
7,400
| – | – |
|